tirzepatide and letrozole Not 👏 A 👏 Fad ! 👏 Notice these trials are all using ?!, There are active recently opened clinical/human trials (& more coming !) testing tirzepatide in breast-cancer populations. Why ? The role of letrozole in

Inhibition of OXM and GLP-1 effects on food intake by exendin-(939)

Months 46: Building Momentum and Lifestyle Integration The 46 month window typically shows cumulative weight loss ranging from 1015% of starting body weight for most patients on consistent tirzepatide therapy

GLP-1 Podcast with Flow Wellness Medical Director Key takeaways from the GLP-1 podcast GLP-1 medications were first developed for diabetes, then became widely used for weight loss after weekly dosing became available

Studies summarized by the American College of Cardiology and pooled in the NIH PMC archive found tirzepatide produced significantly greater average weight loss, though individual results still vary